$SGP
SpyGlass Pharma, Inc. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
$29.08
▼-0.85%-$0.250
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSpyGlass Pharma, Inc. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is SGP down today? It is at $29.08 (-0.85%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SGP spikes, and full due diligence on SGP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SGP 10 times in the last 30 days. Create a free account to track $SGP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SGP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SGP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystSpyGlass Pharma, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Vensana Capital I Gp, Llc Beneficial Owner (10%) | Acquired (grant/award) | +3.15M 9.4% of company | n/a | 3.15M | n/a | Feb 9, 26 |
Vensana Capital I Gp, Llc Beneficial Owner (10%) | Bought (open market) | +165K 0.5% of company | added 5.2% | 3.31M | $2.6M at $16.00 | Feb 9, 26 |
Nielsen Kirk G. Director | Acquired (grant/award) | +3.15M 9.4% of company | n/a | 3.15M | n/a | Feb 9, 26 |
Nielsen Kirk G. Director | Bought (open market) | +165K 0.5% of company | added 5.2% | 3.31M | $2.6M at $16.00 | Feb 9, 26 |
Khan Bilal Arshad Director | Bought (open market) | +20K 0.06% of company | added 100% | 25K | $320K at $16.00 | Feb 9, 26 |
Khan Bilal Arshad Director | Bought (open market) | +115K 0.3% of company | added 84% | 251K | $1.8M at $16.00 | Feb 9, 26 |
Pardo Geoffrey B Director | Acquired (grant/award) | +1.88M 5.6% of company | n/a | 1.88M | n/a | Feb 9, 26 |
Pardo Geoffrey B Director | Bought (open market) | +313K 0.9% of company | added 17% | 2.19M | $5.0M at $16.00 | Feb 9, 26 |
Walker Paul Edward Beneficial Owner (10%) | Bought (open market) | +938K 2.8% of company | added 18% | 6.04M | $15.0M at $16.00 | Feb 9, 26 |
Walker Paul Edward Beneficial Owner (10%) | Acquired (grant/award) | +6.45M 19.3% of company | added 100% | 7.39M | n/a | Feb 9, 26 |
Chang Carmen Beneficial Owner (10%) | Bought (open market) | +938K 2.8% of company | added 18% | 6.04M | $15.0M at $16.00 | Feb 9, 26 |
Chang Carmen Beneficial Owner (10%) | Acquired (grant/award) | +6.45M 19.3% of company | added 100% | 7.39M | n/a | Feb 9, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
Here is the latest on SGP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SGP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SGP last traded at $29.08, down 0.85% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
SpyGlass Pharma, Inc. Common Stock (SGP) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. SGP currently has a dividend yield of about 0.89% ($0.26 per share per year). Dividend figures can change; this is not investment advice.
The SGP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SGP 10 times in the last 30 days.
SGP (SpyGlass Pharma, Inc. Common Stock) trades on XNAS, with a market cap of about $973M in the Surgical & Medical Instruments & Apparatus sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SGP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SGP discussion
Sign in to ask a question or join the discussion.